Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CRISPR-Cas12a-based detection and differentiation of Mycobacterium spp

24 Dec 2024

Abstract excerpt

• MyTRACK uses recombinase polymerase amplification and CRISPR-Cas12a for detection. • Accurately identifies eight mycobacterial strains in clinical isolates. • Detects 1-100 copies/reaction with high specificity and sensitivity. • Fast, portable, and user-friendly, ideal for low-resource clinical environments. Mycobacterium species cause several vital human diseases, including tuberculosis and non-tuberculous...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Mycobacterium research and diagnosis

Source

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Identifiers

PMID: 39725131
DOI: 10.1016/j.cca.2024.120101

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 20 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CRISPR-Cas12a-based detection and differentiation of Mycobacterium sppPMID 39725131Read ↗

ERA-CRISPR/Cas12a system: a rapid, highly sensitive and specific assay for Mycobacterium tuberculosisSemantic proximity Read ↗

Development of CRISPR/Cas12b-Based Multiple Cross Displacement Amplification Technique for the Detection of Mycobacterium tuberculosis Complex in Clinical SettingsSemantic proximity Read ↗

A CRISPR-Cas12a-based platform for ultrasensitive rapid highly specific detection of Mycobacterium tuberculosis in clinical applicationSemantic proximity Read ↗

Development and preliminary assessment of a CRISPR–Cas12a-based multiplex detection of Mycobacterium tuberculosis complexSemantic proximity Read ↗

Rapid and Highly Sensitive Detection of Mycobacterium tuberculosis Utilizing the Recombinase Aided Amplification-Based CRISPR-Cas13a SystemSemantic proximity Read ↗

A Streamlined Point-of-Care CRISPR Test for Tuberculosis Detection Directly from SputumSemantic proximity Read ↗

A new method for the detection of Mycobacterium tuberculosis based on the CRISPR/Cas systemSemantic proximity Read ↗

A streamlined CRISPR-based test for tuberculosis detection directly from sputumSemantic proximity Read ↗

Development and clinical evaluation of a CRISPR/Cas13a-based diagnostic test to detect Mycobacterium tuberculosis in clinical specimensSemantic proximity Read ↗

An accurate and convenient method for Mycoplasma pneumoniae via one-step LAMP-CRISPR/Cas12b detection platformSemantic proximity Read ↗

A Recombinase Polymerase Amplification-Coupled Cas12a Mutant-Based Module for Efficient Detection of Streptomycin-Resistant Mutations in Mycobacterium tuberculosisSemantic proximity Read ↗

Ultrasensitive, Specific, and Rapid Detection of Mycoplasma pneumoniae Using the ERA/CRISPR–Cas12a Dual SystemSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.